Previous Publications
Previous Publications
October 2021
- Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination
Nature, October 21, 2021 - Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine, October 18, 2021 - Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines
NEJM, October 15, 2021 - Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021
CDC, 2021 - Immunogenicity of a BNT162b2 vaccine booster in health-care workers
The Lancet Microbe, October 11, 2021 - Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
NEJM, October 6, 2021 - Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
The Lancet, October 4, 2021 - The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
Cell Molecular Therapy, October 1, 2021 - The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
The Lancet Microbe, October 1, 2021
September 2021
- COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
The Lancet Respiratory Medicine, September 29, 2021 - High affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
Cell Reports, September 24, 2021 - Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
NEJM, September 23, 2021 - Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study
The Lancet Infectious Diseases, September 22, 2021 - Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against re-infection with B.1.1.7 and B.1.351 variants
Science Translational Medicine, September 21, 2021 - High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Nature, September 20, 2021 - Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
Science, September 14, 2021 - SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
NJEM, September 16, 2021 - Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
The Lancet Infectious Disease, September 9, 2021 - A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
Science, September 9, 2021 - Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
Science Immunology, September 2, 2021 - Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
The Lancet, September 1, 2021
August 2021
- New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
CDC, August 27, 2021 - Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
The Lancet, August 27, 2021 - Profiling CD8+ T Cell Epitopes of COVID-19 Convalescents Reveals Reduced Cellular Immune Responses to SARS-CoV-2 Variants
Cell Reports, August 26, 2021 - Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
NEJM, August 25, 2021 - mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
BioRxiv, August 23, 2021 - A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Cell, August 18, 2021 - The Origins of SARS-CoV-2: A Critical Review
Cell, August 18, 2021 - SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
The Lancet Correspondence, August 17, 2021 - Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
The Lancet Infectious Diseases, August 16, 2021 - Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
Science, August 12, 2021 - Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
NEJM, August 11, 2021 - Performance of saliva and mid-turbinate swabs for detection of the beta variant in South Africa
The Lancet Infectious Disease, August 4, 2021 - Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals
Cell Reports, August 3, 2021 - Broad betacoronavirus neutralization by a stem helix–specific human antibody
Science, August 3, 2021 - Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms
Cell iScience, August 1, 2021
July 2021
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
CDC, July 30, 2021 - Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
NEJM, July 28, 2021 - Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
Nature Communications, July 26, 2021 - Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated with Effective Immune Response to SARS-CoV-2 in BNT162b2 mRNA Vaccine Recipients
Cell Reports, July 22, 2021 - Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
NEJM, July 21, 2021 - Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
The Lancet, July 13, 2021 - Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes
PNAS, July 27, 2021 - Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Nature Medicine, July 14, 2021 - Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Nature, July 12, 2021 - Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Nature, July 8, 2021 - A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation
Cell, July 6, 2021
June 2021
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
NEJM, June 30, 2021 - Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Nature, June 30, 2021 - SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Nature, June 28, 2021 - Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Science, June 24, 2021 - Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
Nature, June 23, 2021 - In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Nature, June 21, 2021 - Immunogenicity of SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer
Cancer Cell, June 18, 2021 - SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Cell, June 14, 2021 - Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Nature, June 14, 2021 - Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany
CDC, June 8, 2021 - SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD and S2
Cell, June 8, 2021 - Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
NEJM, June 2, 2021
May 2021
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
NEJM, May 27, 2021 - SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
Science Immunology, May 25, 2021 - Activate-2: a Double-blind Randomized Trial of BCG Vaccination Against Covid-19 in Individuals at Risk
Medrxiv, May 24, 2021 - Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Science, May 20, 2021 - Analysis of 472,688 severe cases of COVID-19 in Brazil showed lower mortality in those vaccinated against influenza
Medrxiv, May 14, 2012 - Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
Proc Natl Acad Sci, May 25, 2021 - Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
Nature, May 16, 2021 - Do coronavirus genes slip into human chromosomes?
Science, May 14, 2021 - Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
JAMA, May 13, 2021 - Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
PNAS, May 2021 - Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts
Nature, May 6, 2021 - Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress
Nature, May 6, 2021 - Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
NEJM, May 5, 2021 - Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
NEJM, May 5, 2021 - Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
The Lancet, May 5, 2021 - Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset
Cell, May 4, 2021
April 2021
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Science, April 30, 2021 - Conformational flexibility and structural variability of SARS-CoV2 S protein
Cell, April 30, 2021 - Longitudinal proteomic analysis of plasma from patients with severe COVID-19 reveal patient survival-associated signatures, tissue-specific cell death, and cell-cell interactions
Cell, April 30, 2021 - Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients
Cell, April 30, 2021 - SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study
The Lancet, April 29, 2021 - Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Cell Medicine, April 20, 2021 - Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Cell, April 20, 2021 - Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
Cell Host and Microbe, April 17, 2021 - BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel
Cell, April 17, 2021 - Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
Nature, April 16, 2021 - Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
NEJM, April 16, 2021 - Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Science, April 14, 2021 - Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
Science, April 12, 2021 - Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis
The Lancet, April 12, 2021
March 2021
- TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
Cell, March 30, 2021 - Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Cell, March 30, 2021 - Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021
Medrxiv, March 30, 2021 - Enrichment of SARS-CoV-2 entry factors and interacting intracellular genes in peripheral immune cells
Biorxiv, March 29, 2021 - A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations
Medrxiv, March 29, 2021 - Recombinant SARS-CoV-2 genomes involving lineage B.1.1.7 in the UK
Virological.org, March 17, 2021 - Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases
Nature, March 15, 2021 - FDA Fact sheet for health care providers: emergency use authorization (EUA) of bamlanivimab.
FDA, March 2021 - Low SARS-CoV-2 Transmission in Elementary Schools — Salt Lake County, Utah, December 3, 2020–January 31, 2021
CDC, March 26, 2021 - Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Nature, March 25, 2021 - SARS-CoV-2 infection of the oral cavity and saliva
Nature, March 25, 2021 - New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
NEJM, March 24, 2021 - The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study
Lancet, March 24, 2021 - Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center
NEJM, March 23, 2021 - Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
NEJM, March 23, 2021 - Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
The Lancet, March 20-26, 2021 - SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Cell, March 20, 2021 - Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?Iran J Immunol, March 18, 2021
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
BMJ, March 10, 2021
February 2021
- Impact of the influenza vaccine on COVID-19 infection rates and severity
American Journal of Infection Control, February 22, 2021 - MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness
American Journal of Medicine, February 1, 2021 - The emergence and ongoing convergent evolution of the N501Y lineages coincided with a major global shift in the SARS-Cov-2 selective landscape
Virological, February 13, 2021 - Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
CDC, February 2021 - What to know about J&J’s FDA-authorized one-shot COVID-19 vaccine
Science News, February 27, 2021 - Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
NEJM, February 25, 2021 - Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
NEJM, February 25, 2021 - Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
Authorea, February 24, 2021 - Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody | Science
Science, February 19, 2021 - Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine (Moderna)— Preliminary Report
- NEJM, February 17, 2021
- Neutralizing Activity of BNT162b2 (Pfizer)-Elicited Serum — Preliminary Report
NEJM, February 17, 2021 - Humoral signatures of protective and pathological SARS-CoV-2 infection in children
Nature Medicine, February 12, 2021
January 2021
2020
- Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
mBio, November 2, 2020 - The effect of influenza vaccination on trained immunity: impact on COVID-19
Medrxiv, October 16, 2020 - Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil
BMJ, 2020